首页> 外国专利> AEROSOL FORMULATIONS OF BUTALBITAL, LORAZEPAM, IPRATROPIUM, BACLOFEN, MORPHINE AND SCOPOLAMINE

AEROSOL FORMULATIONS OF BUTALBITAL, LORAZEPAM, IPRATROPIUM, BACLOFEN, MORPHINE AND SCOPOLAMINE

机译:丁巴比妥,洛拉西M,异丙草铵,巴氯芬,吗啡和东POL碱的气雾剂配方

摘要

A liquid aerosol formulation comprising at least one thermally stable active ingredient selected from the group consisting of butalbital, lorazepam, ipratropium, baclofen, morphine, scopolamine, pharmaceutically acceptable salts and esters thereof and derivatives thereof. The liquid formulation can include an organic solvent such as propylene glycol and one or more optional excipients. The active ingredient can be present in an amount of 0.01 to 5 weight percent and the formulation can be heated to provide a vapor which forms an aerosol having a mass median aerodynamic diameter of less than 3 µm.
机译:液体气雾剂,其包含至少一种热稳定的活性成分,所述活性成分选自丁比妥,劳拉西m,异丙托铵,巴氯芬,吗啡,东sco碱,其药学上可接受的盐和酯及其衍生物。液体制剂可包含有机溶剂,例如丙二醇和一种或多种任选的赋形剂。活性成分可以以0.01至5重量%的量存在,并且可以加热制剂以提供蒸气,该蒸气形成质量中位数空气动力学直径小于3μm的气溶胶。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号